FDA Updates

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between February 9, 2023, and April 3, 2023.

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between December 9, 2022, and February 3, 2023.

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between October 21, 2022, and December 1, 2022.

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between August 24, 2022, and September 30, 2022.

This section provides a brief overview of new indications for cancer drugs approved by the FDA between June 22, 2022, and August 11, 2022.

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between April 1, 2022, and May 27, 2022.

This section provides a brief overview of new cancer drugs and new indications approved by the FDA between February 28 and March 31, 2022.

This section provides a brief overview of new cancer drugs and new fast-track designations approved by the FDA between January 10, 2022, and January 25, 2022.

This section provides a brief overview of new cancer drugs and indications approved by the FDA between November 29, 2021, and December 15, 2021.

This section provides a brief overview of new cancer drugs and indications approved by the FDA between August 13, 2021, and September 22, 2021.